In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
|
|
- Osborne Owens
- 5 years ago
- Views:
Transcription
1 In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44
2 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial infarction Hypertension Animal models of hypertension 43
3 Cardiovascular diseases Coronary heart disease Congestive heart failure Hypertension Stroke
4 Cardiovascular diseases Major cause of morbidity & mortality 30% of total deaths worldwide 17.1 million in million in % of total death in Iran In America: 2010: $503.2 billion dollars Ischemic heart disease
5 Ischemic heart disease First global cause of death in 2004 Remain the first cause of death in 2030 Acute myocardial infarction Restricted regional flow of blood in coronary vessels Deprivation of myocardial tissue from oxygen and nutrients
6 Impairment of coronary blood supply to the myocardium Thrombosis embolism other acute alterations of coronary atherosclerotic plaques The heart can survive a short period of ischemia and exhibit recovery upon reperfusion but If the ischemic period is too long, tissue injury and cell death will occur
7 Animal models for myocardial infarction
8 Animal models for myocardial infarction Better understanding of disease pathophysiology, and progression of ischemia to myocardial infarction New approaches to diagnosis and treatment of diseases Drug development
9 Animal models for myocardial infarction Various species Large animals: pig, dog, sheep Expensive Require substantial resources for housing and care In several countries, investigations in larger animals are limited due to ethical considerations Small animals: mice, rat, rabbit Small size Easy availability Low maintenance cost
10 Ideal animal model Mimic human diseases Easy to reproduce Chronically stable Suitable for measurements of cardiac size and function Sufficiently economical to allow therapeutic trials
11 Animal models for myocardial infarction In vivo animal models of MI Surgical procedure Pharmacologically-induced models Genetically modified mice Ex vivo models of MI Langendorff heart model In vitro models of isolated cardiac cells
12 Surgical procedure
13 Coronary artery ligation model Occluding of the coronary arteries via thoracotomy to induce MI Ligation of the left anterior descending (LAD) coronary artery to create anterior wall infarction Surgical procedure Under anesthesia the hearts of animals are exposed following a left thoracotomy at the forth intercostal space The pericardium is carefully broken, and the LAD is ligated with a suture placed just distally from tip of the left auricle Permanent ligation of the LAD Irreversible damage to the myocardium Stable and easily reproduced Extensively employed in studies on MI therapies
14 Pharmacologically-induced models Convenient procedure Does not require complicated surgery Isoproterenol, adriyamycin, and ergonovin Increases myocardial oxygen consumption Induces coronary artery spasm Reduce blood flow Drug safety Difficulty in accurately positioning the infarct region
15 Isoproterenol Synthetic β-adrenergic agonist Enhanced catecholamine levels: myocardial hyperactivity: an imbalance between oxygen supply versus demand Administration of isoproterenol in high doses infarct-like necrosis of the heart muscle, which morphologically resembles acute myocardial infarction in humans
16 A single subcutaneous administration of ISO at a dose of mg/kg body weight on two subsequent days ISO get auto oxidize into reactive oxygen species (ROS) Alters membrane permeability Increase the level of cardiac specific enzymes, low density lipoprotein (LDL), cholesterol Decreases the endogenous antioxidant enzyme levels widely used animal model Assessment of cardio protective activity of natural as well as synthetic compounds
17 Cardiovascular effects of acute myocardial infarction Cardiac structural and hemodynamic changes Echocardiographic parameters Left ventricular structural and functional abnormalities including increased systolic and diastolic left ventricular internal diameter, decreased EF and FS Hemodynamic parameters Reduction of LVSP, + dp/dt, -dp/dt and cardiac output, and elevation of LVEDP Increased serum levels of Cardiac troponin I Creatine kinase-mb (CK-MB) Lactate dehydrogenase (LDH)
18 Ex vivo models of MI Langendorff heart model German physiologist Oskar Langendorff Isolated heart model Excellent model for understanding the consequences of acute as well as chronic myocardial ischemia Advantages over in vivo MI models Easy to understand the pathophysiological changes and well controlled environmental conditions and elimination of hemodynamic and neurohumoral hindrances
19
20 Hypertension One billion individuals worldwide Major risk factor Myocardial infarction and heart failure Primary or essential hypertension: idiopathic Secondary hypertension Less than 20% of cases of hypertension
21 Effects of hypertension on cardiac functions Left ventricular hypertrophy Atrial fibrillation, ventricular arrhythmias and sudden cardiac death Three- to four-fold increase in the risk of stroke, Three- to four-fold increase in the risk of stroke, coronary heart disease, and peripheral arterial diseases
22 Effects of hypertension on vascular functions Changes in vascular endothelial functions: endothelial dysfunction Augmented vascular contractile responses to various vasoconstrictor agents Increased contraction responses to phenylephrine, potassium chloride, angiotensin II Impairment of relaxation response to vasodilator agents Decreased endothelium-dependent relaxation to Ach Unchanged endothelium-independent relaxation to sodium nitroprusside (SNP)
23 Animal models of hypertension Provided valuable information regarding many aspects of HTN Etiology Pathophysiology Complications Treatment The choice of animal model Research question Limitations Technical expertise
24 Animal models of HTN Renovascular Renal parenchymal Pharmacologically induced Genetic models
25 Etiology of HTN is heterogeneous Primary ( essential ) Etiology: unclear Interaction of multiple genetic and environmental factors Secondary to a defined process Renal artery stenosis
26 Ideal animal model for HTN research Human-like cardiovascular anatomy, hemodynamics, and physiology Develop the human HTN characteristics and complications Allow studies in chronic stable HTN Allow measurement of relevant hemodynamic and biochemical parameters
27 Renovascular HTN Goldblatt First animal models of HTN HTN in dogs by unilateral clamping of the renal artery 2-kidney, 1-clip (2K-1C) 2-kidney, 2-clip (2K-2C) 1-kidney, 1-clip (1K-1C)
28 2K-1C Model Both native kidneys: left intact Constricting clip (to resemble a clinical stenosis): placed on 1 renal artery In the absence of damage to the contralateral kidney Classic renin dependent model 2K-1C HTN Decreased renal arterial pressure in the clipped kidney Increase in plasma renin activity (PRA)
29 1K-1C Model unilateral nephrectomy placement of a constricting clip on the renal artery of the remaining kidney resembles patients who have only a solitary kidney and a significant renal artery stenosis in that kidney
30 Stimulation of the renin angiotensin aldosterone system Initial elevation of blood pressure Renin-angiotensin system (RAS) dependent In the absence of renal excretion or fluid loss Retention of water and salt Volume-overload form of hypertension
31 2K-2C Model Both renal arteries are constricted Less often used
32 Renal Parenchymal HTN Reduced Renal Mass Salt-Induced Model Clinically, the most common secondary cause of HTN is a loss of renal function from any cause The animal model that most closely approximates this clinical condition is the reduced renal mass model a renal mass reduction of >85% is required unilateral nephrectomy followed by surgical removal of two-thirds of the remaining kidney By itself, this degree of renal mass reduction results in only a slight BP increase compared with sham-operated, normotensive control animals A further increase in BP is provoked by the administration of excess salt in the drinking water or in the food PRA is low and the HTN is salt-dependent
33 Pharmacologically Induced HTN Deoxycorticosterone Acetate-Salt Induced Model Resembles the clinical situation of aldosterone excess Unilateral nephrectomy followed by administration of DOCA along with excess salt (usually, 0.9% NaCl drinking water)
34 Genetic Models of Hypertension Inbred Rat Models Discovery of individual animals spontaneously having high BP without any surgical or pharmacological intervention Genetic homogeneity is achieved by sibling mating of these hypertensive rat strains over several generations Spontaneously Hypertensive Rats (SHR) Dahl salt-sensitive rats
35 Spontaneously Hypertensive Rats Develop HTN and target organ damage similar to human essential HTN Pathophysiological changes are similar to those found in human essential HTN The pathogenesis of HTN in the SHR appears to be heterogeneous: CNS, neurohumoral, renal, and cellular abnormalities Screening of potential pharmacologic antihypertensive agents, and in the investigation of genetic determinants of high BP
36 Dahl salt-sensitive rats Requires administration of increased dietary sodium for BP elevation High-salt diets (8% NaCl enriched diet) Develop severe HTN
37 Conclusions No model mimics all traits of human hypertension choice of the animal model for HTN research research question Limitations technical expertise Models with an unknown etiology of HTN, such as genetic models (eg, SHR, Dahl) provide an opportunity to search for new mechanisms and new genes in HTN Models with a relatively known etiology of HTN, such as DOCA-salt models and Goldblatt models more useful in studying the neurohumoral mechanisms and the effects of elevated BP on target organs
38
Ischemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationHeart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United
Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually
More informationHYPERTENSIVE VASCULAR DISEASE
HYPERTENSIVE VASCULAR DISEASE Cutoffs in diagnosing hypertension in clinical practice sustained diastolic pressures >90 mm Hg, or sustained systolic pressures >140 mm Hg Malignant hypertension A small
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationFunctional vascular disorders
Functional vascular disorders Raynaud s phenomenon Raynaud s phenomenon Refers to Intermittent,bilateral attacks of ischemia of the fingers or toes, and sometimes ears or nose. It clinically manifests
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationCoral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.
Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationHypertension. Penny Mosley MRPharmS
Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines
More informationHEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body
More informationβ adrenergic blockade, a renal perspective Prof S O McLigeyo
β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationRenal Denervation. Henry Krum MBBS PhD FRACP. Centre of Cardiovascular Research & Monash University/Alfred Hospital;
Renal Denervation Henry Krum MBBS PhD FRACP Centre of Cardiovascular Research & Education in Therapeutics, Monash University/Alfred Hospital; Alfred Heart Centre, The Alfred Hospital, Melbourne Australia
More informationObjectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?
Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation
More informationCardiac Pathology & Rehabilitation
Cardiac Pathology & Rehabilitation Which of the following best describes the physical activity performed in my leisure time? A. I perform vigorous physical activity 3X/week for 20 minutes each time B.
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationStructure and organization of blood vessels
The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins
More informationPathology of Hypertension
2016-03-07 Pathology of Hypertension Honghe Zhang honghezhang@zju.edu.cn Tel:88208199 Department of Pathology ❶ Genetic predisposition ❷ Dietary factors ❸ Environmental factors ❹ Others Definition and
More informationSPECIAL PATHOPHYSIOLOGY CARDIO-VASCULAR SYSTEM
1. Myocardia lischemia is mainly a result of: 1.Coronary hypoxemia. 2. Coronary artery disease (CAD). 3. Acute coronaritis. 4. Coronary anemia. 5. Heart remodelling. SPECIAL PATHOPHYSIOLOGY CARDIO-VASCULAR
More informationHeart Failure. Acute. Plasma [NE] (pg/ml) 24 Hours. Chronic
Heart Failure Heart failure is the inability of the heart to deliver sufficient blood to the tissues to ensure adequate oxygen supply. Clinically it is characterized by signs of volume overload or symptoms
More information1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).
1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI). 5- cardiogenic shock (massive MIs >40% of the left ventricle)
More informationLeft ventricular hypertrophy: why does it happen?
Nephrol Dial Transplant (2003) 18 [Suppl 8]: viii2 viii6 DOI: 10.1093/ndt/gfg1083 Left ventricular hypertrophy: why does it happen? Gerard M. London Department of Nephrology and Dialysis, Manhes Hospital,
More informationHYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg
Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationHypertensives Emergency and Urgency
Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of
More informationPathophysiology: Heart Failure
Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationObjectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2
10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves
More informationResults of Ischemic Heart Disease
Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationOutline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies
Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the
More informationCardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology
Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart
More informationHypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union
Hypertension and Heart Disease Weldon James, MD, Mercy Clinic Family Medicine, Union The Silent Killer High blood pressure, also known as HBP or hypertension, is a widely misunderstood medical condition
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationM2 TEACHING UNDERSTANDING PHARMACOLOGY
M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To
More informationMcHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload
McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload Cardiac output (CO) represents the volume of blood that is delivered
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More information1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias
1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should
More informationTYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016
TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More informationAntihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationBIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.
BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS As. MARUSHCHAK M.I. Heart attack symptoms Acute MI Measurement of cardiac enzyme levels Measure cardiac enzyme levels at regular
More informationCardiac Pathology 2: Heart Failure, Ischemic Heart Disease and other assorted stuff. Kris=ne Kra>s, M.D.
Cardiac Pathology 2: Heart Failure, Ischemic Heart Disease and other assorted stuff Kris=ne Kra>s, M.D. Cardiac Pathology Outline Blood Vessels Heart I Heart II Cardiac Pathology Outline Blood Vessels
More informationELECTROPHYSIOLOGICAL CHANGES DURING MYOCARDIAL ISCHAEMIA
ELECTROPHYSIOLOGICAL CHANGES DURING MYOCARDIAL ISCHAEMIA 1. Definition of myocardial ischaemia "The blood supply to the myocardium is inadequate" (Opie) "The absence of arterial blood flow" (Jennings)
More informationMWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient
MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient In this CE we will discuss the patient presenting with an acute ST-Elevation Myocardial Infarction (STEMI) Definition: Myocardial
More informationPhysiological Response to Hypovolemic Shock Dr Khwaja Mohammed Amir MD Assistant Professor(Physiology) Objectives At the end of the session the
Physiological Response to Hypovolemic Shock Dr Khwaja Mohammed Amir MD Assistant Professor(Physiology) Objectives At the end of the session the students should be able to: List causes of shock including
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationHypertension Coronary artery disease
Hypertension Coronary artery disease 1 Problem Magnitude Hypertension( HTN) is the most common primary diagnosis. Worldwide prevalence estimates for HTN may be as much as 1 billion. Arterial hypertension
More informationBUSINESS. Articles? Grades Midterm Review session
BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization
More informationPathophysiology of Coronary Microvascular Dysfunction
Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive
More informationCopyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy
Mosby,, an affiliate of Elsevier Normal Cardiac Anatomy Impaired cardiac pumping Results in vasoconstriction & fluid retention Characterized by ventricular dysfunction, reduced exercise tolerance, diminished
More informationSECONDARY HYPERTENSION
HYPERTENSION Hypertension is the clinical term used to describe a high blood pressure of 140/90 mmhg or higher (National Institute of Health 1997). It is such a health risk the World Health Organisation
More informationCoronary heart disease (CHD)
1 Coronary heart disease (CHD) 2 Institute of Pathological Physiology Martin Vokurka mvoku@lf1.cuni.cz Winter Semester 3 CORONARY CIRCULATION AND MYOCARDIAL METABOLISM 4 Blood flow: resting: 250 ml/min
More informationIschemic Heart Disease
Ischemic Heart Disease Dr Rodney Itaki Lecturer Division of Pathology University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Consideration Results from partial
More informationCardiovascular Diseases and Diabetes
Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationSupplemental Figure I
Supplemental Figure I Kl ( mmol/l)-induced Force orta M (mn) 1 (mn) 1 Supplemental Figure I. Kl-induced contractions. and, Kl ( mmol/l)-induced contractions of the aorta () and those of mesenteric arteries
More informationSection 5.1 The heart and heart disease
Section 5.1 The heart and heart disease Mammals are too large to rely on diffusion. They need a circulatory system to move substances around the body. Blood moves down pressure gradients, from high to
More informationHeart failure congestive heart failure, or CHF
Heart failure Heart failure (also called congestive heart failure, or CHF) is a frequent end point of many of the conditions In the United States alone, CHF affects nearly 5 million individuals annually,
More informationCrisis Management During Liver Transplant Surgery Liver and Intensive Care Group of Europe Newcastle upon Tyne 2005
Crisis Management During Liver Transplant Surgery Liver and Intensive Care Group of Europe Newcastle upon Tyne 2005 M. Susan Mandell M.D. Ph. D. Department of Anesthesiology University of Colorado Health
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationTherefore MAP=CO x TPR = HR x SV x TPR
Regulation of MAP Flow = pressure gradient resistance CO = MAP TPR Therefore MAP=CO x TPR = HR x SV x TPR TPR is the total peripheral resistance: this is the combined resistance of all blood vessels (remember
More informationIntroduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring
Introduction Invasive Hemodynamic Monitoring Audis Bethea, Pharm.D. Assistant Professor Therapeutics IV January 21, 2004 Hemodynamic monitoring is necessary to assess and manage shock Information obtained
More information10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor
Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure
More informationElements for a public summary
VI.2 Elements for a public summary VI.2.1Overview of disease epidemiology 1 Losartan is indicated for: Treatment of essential hypertension in adults and in children and adolescent 6 18 years of age. Treatment
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationProcess Measure: Screening for Adult Obstructive Sleep Apnea
Process Measure: Screening for Adult Obstructive Sleep Apnea Measure Description Description Type of Measure All patients aged 18 years and older at high risk for obstructive sleep apnea (OSA) with documentation
More informationUCLA Nutrition Bytes. Title. Permalink. Journal ISSN. Author. Publication Date. Calcium and Hypertension. https://escholarship.org/uc/item/68b658ss
UCLA Nutrition Bytes Title Calcium and Hypertension Permalink https://escholarship.org/uc/item/68b658ss Journal Nutrition Bytes, 4(2) ISSN 1548-601X Author Martinez, Christina Publication Date 1998-01-01
More informationDysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias
Dysrhythmias Dysrythmias & Anti-Dysrhythmics Rhythm bad in the heart: Whitewater rafting Electrical impulses coordinate heart Reduction in Cardiac Output PEA Asystole Components of an ECG Wave EKG Parameters
More information*Sections or subsections omitted from the full prescribing information are not listed.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GIAPREZA TM safely and effectively. See full prescribing information for GIAPREZA. GIAPREZA (angiotensin
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationLab 16. The Cardiovascular System Heart and Blood Vessels. Laboratory Objectives
Lab 16 The Cardiovascular System Heart and Blood Vessels Laboratory Objectives Describe the anatomical structures of the heart to include the pericardium, chambers, valves, and major vessels. Describe
More informationHypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure
More informationAmlodipine plus Lisinopril Tablets AMLOPRES-L
Amlodipine plus Lisinopril Tablets AMLOPRES-L COMPOSITION AMLOPRES-L Each uncoated tablet contains: Amlodipine besylate equivalent to Amlodipine 5 mg and Lisinopril USP equivalent to Lisinopril (anhydrous)
More informationCardiac Ischemia (is-kē-mē-uh)
Chapter 21 Cardiac Ischemia (is-kē-mē-uh) By: Alejandra & Lindsay I. Cardiac Ischemia =the most common cause of death in Western Culture ~35% of deaths. -Suddenly from acute coronary occlusion or fibrillation
More informationPathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD
Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More informationCKD Satellite Symposium
CKD Satellite Symposium Recommended Therapy by Heart Failure Stage AHA/ACC Task Force on Practice Guideline 2001 Natural History of Heart Failure Patients surviving % Mechanism of death Sudden death 40%
More informationP F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia
Disorder of the Breast Approach to the Patient with Chest Pain Anthony J. Minisi, MD Department of Internal Medicine, Division of Cardiology Virginia Commonwealth University School of Medicine William
More informationPharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)
Lecture 7 (year3) Dr Noor Al-Hasani Pharmacology University of Baghdad College of dentistry Drugs affecting the Cardiovascular system (Antianginal Drugs) Atherosclerotic disease of the coronary arteries,
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationBIOL 219 Spring Chapters 14&15 Cardiovascular System
1 BIOL 219 Spring 2013 Chapters 14&15 Cardiovascular System Outline: Components of the CV system Heart anatomy Layers of the heart wall Pericardium Heart chambers, valves, blood vessels, septum Atrioventricular
More informationRENAL ARTERY STENOSIS. Grand Rounds 10/11/2011
RENAL ARTERY STENOSIS Grand Rounds 10/11/2011 ARAS Prevalence- 0.5% overall population, 5.5% in ckd pts No correlation between ischemic nephropathy and severity of stenosis Increased risk of vascular events-
More informationMedical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine
Medical Management of Acutely Decompensated Heart Failure William T. Abraham, MD Director, Division of Cardiovascular Medicine Orlando, Florida October 7-9, 2011 Goals of Acute Heart Failure Therapy Alleviate
More information